EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

Assessment of serum level of galectin-9 in systemic lupus erythematosus patients in Tanta University hospitals, case-control research

Aya Hamed Ahmed Abdelgalil, Radwa Mahmoud Elsharaby, Salwa Elmorsy Abd EIGhany, Wesam Salah Ibrahim

Journal of Investigative Medicine · 2026

DOI: 10.1177/10815589251333729 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Journal of Investigative Medicine, 2026. Verfasst von Aya Hamed Ahmed Abdelgalil und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, Tanta Faculty of Medicine, Tanta, Egypt. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Galectins, Hospitals, University. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Maryland State Department of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Galectin-9 (Gal-9) has a significant regulatory function in autoimmune disorders, including systemic lupus erythematosus (SLE). The objective of this study was to assess the blood levels of Galectin-9 in patients with SLE and investigate the correlation between the protein and disease activity. The study employed a case-control design involving 75 participants, aged between 25 and 55 years, representing both sexes, all of whom had been diagnosed with SLE and were either in a quiescent or active phase of the disease. Three equal groups of participants were created. It was shown that Galectin-9 has 88% sensitivity and 80% specificity, with an area under the curve (AUC) of 0.901. With a computed positive predictive value of 81% and a negative predictive value of 87%, the total accuracy was 84%. In addition, a strong positive connection (R = 0.606) was found between anti-double strand DNA and Gal-9 levels, urea (R = 0.482), creatinine (R = 0.530), proteinuria (R = 0.488), albumin-to-creatinine ratio (R = 0.7), and SLEDAI (R = 0.815) and there is negative correlation with hemoglobin (R = −0.772), white blood cells (R = −0.849), platelets (R = −0.481), and complement 3 (R = −0.578). Compared to healthy persons, patients with SLE had considerably higher serum concentrations of Gal-9. Patients without active illness did not have elevated levels of Gal-9; those with active SLE did. Moreover, Gal-9 showed a robust association with the activity of SLE illness, indicating a possible involvement in the onset of SLE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicGalectinsHospitals, UniversityHumansFemaleMaleAdultCase-Control StudiesMiddle Aged

Stichwörter der Autor:innen

Autoimmune diseasesGalectin-9serum levelsystemic lupus erythematosus

Substanzen

GalectinsLGALS9 protein, human

Autor:innen und Institutionen

  • Department of Clinical Pathology, Tanta Faculty of Medicine, Tanta, Egypt.
  • Department of Rheumatology, Physical Medicine and Rehabilitation, Tanta Faculty of Medicine, Tanta, Egypt.

Förderung

  • Maryland State Department of Education

Zitieren

APA

Abdelgalil, A. H. A., Elsharaby, R. M., Abd EIGhany, S. E., & Ibrahim, W. S. (2026). Assessment of serum level of galectin-9 in systemic lupus erythematosus patients in Tanta University hospitals, case-control research. Journal of Investigative Medicine. https://doi.org/10.1177/10815589251333729

Vancouver

Abdelgalil AHA, Elsharaby RM, Abd EIGhany SE, Ibrahim WS. Assessment of serum level of galectin-9 in systemic lupus erythematosus patients in Tanta University hospitals, case-control research. Journal of Investigative Medicine. 2026. doi:10.1177/10815589251333729

BibTeX
@article{Abdelgalil2026,
  author = {Abdelgalil, Aya Hamed Ahmed and Elsharaby, Radwa Mahmoud and Abd EIGhany, Salwa Elmorsy and Ibrahim, Wesam Salah},
  title = {Assessment of serum level of galectin-9 in systemic lupus erythematosus patients in Tanta University hospitals, case-control research},
  journal = {Journal of Investigative Medicine},
  year = {2026},
  doi = {10.1177/10815589251333729}
}
Kostenlos starten →